Real-world experience of regorafenib in patients with hepatocellular carcinoma: A multicenter United Kingdom study

被引：0
|
作者：
Ross, Paul J.
Ma, Yuk Ting
Palmer, Daniel H.
Lythgoe, Mark Peter
Merrick, Sophie
Samson, Adel
Rao, Ankit Rohit
Basu, Bristi
Prasad, Debi
Dhillon, Tony
Lau, David
Darby, Suzanne
Orr, James
Margetts, Jane
Hubner, Richard
Baijal, Shobhit
Sharma, Rohini
Faluyi, Olusola Olusesan
Lee, Lennard
Thillai, Kiruthikah
机构：
[1] Guys & St Thomas NHS Fdn Trust, London, England
[2] Kings Coll Hosp NHS Fdn Trust, London, England
[3] Univ Birmingham, Birmingham, W Midlands, England
[4] Univ Liverpool, Liverpool, Merseyside, England
[5] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[6] Imperial Coll London, London, England
[7] East & North Herts NHS Trust, Stevenage, Herts, England
[8] Univ Leeds, Leeds, W Yorkshire, England
[9] Nottingham City Hosp, Nottingham, England
[10] Univ Cambridge, Cambridge, England
[11] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[12] Kings Coll Hosp London, London, England
[13] Univ Surrey, Royal Surrey Hosp, Guildford, Surrey, England
[14] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[15] Weston Pk Hosp, Sheffield, S Yorkshire, England
[16] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England
[17] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[18] Christie NHS Fdn Trust, Manchester, Lancs, England
[19] Birmingham Heartlands Hosp, Birmingham, W Midlands, England
[20] Clatterbridge Canc Ctr, Wirral, Merseyside, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
499
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
    Mara Persano
    Margherita Rimini
    Toshifumi Tada
    Goki Suda
    Shigeo Shimose
    Masatoshi Kudo
    Jaekyung Cheon
    Fabian Finkelmeier
    Ho Yeong Lim
    Lorenza Rimassa
    José Presa
    Gianluca Masi
    Changhoon Yoo
    Sara Lonardi
    Francesco Tovoli
    Takashi Kumada
    Naoya Sakamoto
    Hideki Iwamoto
    Tomoko Aoki
    Hong Jae Chon
    Vera Himmelsbach
    Tiziana Pressiani
    Takumi Kawaguchi
    Margarida Montes
    Caterina Vivaldi
    Caterina Soldà
    Fabio Piscaglia
    Atsushi Hiraoka
    Takuya Sho
    Takashi Niizeki
    Naoshi Nishida
    Christoph Steup
    Massimo Iavarone
    Giovanni Di Costanzo
    Fabio Marra
    Mario Scartozzi
    Emiliano Tamburini
    Giuseppe Cabibbo
    Francesco Giuseppe Foschi
    Marianna Silletta
    Masashi Hirooka
    Kazuya Kariyama
    Joji Tani
    Masanori Atsukawa
    Koichi Takaguchi
    Ei Itobayashi
    Shinya Fukunishi
    Kunihiko Tsuji
    Toru Ishikawa
    Kazuto Tajiri
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5591 - 5602
  • [32] A real-world study of TACE combined with regorafenib as a second-line treatment for advanced hepatocellular carcinoma
    Liu, Shaoxing
    Gao, Song
    Guo, Jianhai
    Kou, Fuxin
    Zhang, Xin
    Liu, Baojiang
    Feng, Aiwei
    Wang, Xiaodong
    Chen, Hui
    Zhu, Xu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Efficacy and safety of TACE combined with ablation and regorafenib for unresectable hepatocellular carcinoma: A real-world study.
    Xiong, Yiqi
    Gao, WenFeng
    Long, Jiang
    Hu, CaiXia
    Yuan, ChunWang
    Sun, Yu
    Shi, QinSheng
    Sun, Bin
    Zhang, YingHua
    Cui, XiongWei
    Hao, MeiJun
    Li, Jianjun
    Zhang, Yonghong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study
    Patwala, Kurvi
    Prince, David Stephen
    Celermajer, Yael
    Alam, Waafiqa
    Paul, Eldho
    Strasser, Simone Irene
    McCaughan, Geoffrey William
    Gow, Paul
    Sood, Siddharth
    Murphy, Elise
    Roberts, Stuart
    Freeman, Elliot
    Stratton, Elizabeth
    Davison, Scott Anthony
    Levy, Miriam Tania
    Clark-Dickson, Mccawley
    Vi Nguyen
    Bell, Sally
    Nicoll, Amanda
    Bloom, Ashley
    Lee, Alice Unah
    Ryan, Marno
    Howell, Jessica
    Valaydon, Zina
    Mack, Alexandra
    Liu, Ken
    Dev, Anouk
    HEPATOLOGY INTERNATIONAL, 2022, 16 (05) : 1170 - 1178
  • [35] Real-world role of performance status in surgical resection for hepatocellular carcinoma: A multicenter study
    Wu, Han
    Xing, Hao
    Liang, Lei
    Huang, Bin
    Li, Chao
    Lau, Wan Yee
    Zhou, Ya-Hao
    Gu, Wei-Min
    Wang, Hong
    Chen, Ting-Hao
    Zhang, Yao-Ming
    Zeng, Yong-Yi
    Pawlik, Timothy M.
    Wang, Ming-Da
    Wu, Meng-Chao
    Shen, Feng
    Yang, Tian
    EJSO, 2019, 45 (12): : 2360 - 2368
  • [36] Real-world dosing of regorafenib in patients with unresectable hepatocellular carcinoma (uHCC): Final analysis of the prospective, observational REFINE study.
    Finn, Richard S.
    Merle, Philippe
    Ikeda, Masafumi
    Klumpen, Heinz-Josef
    Masi, Gianluca
    Granito, Alessandro
    Lim, Ho Yeong
    Kudo, Masatoshi
    Qin, Shukui
    Gerolami, Rene
    Huang, Yi-Hsiang
    Kim, Do Young
    Pinter, Matthias
    Kato, Naoya
    Kurosaki, Masayuki
    Numata, Kazushi
    Khan, Javeed
    Ozgurdal, Kirhan
    Kim, Yoon Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 518 - 518
  • [37] A real-world study of Chinese hepatocellular carcinoma patients treated with TACE
    Hu, H-F
    Sang, Y-F
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (09) : 3091 - 3099
  • [38] ANALYSIS OF FACTORS RELATED TO THE TOLERABILITY OF LENVATINIB FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CONDITIONS: A MULTICENTER STUDY
    Taniki, Nobuhito
    Nakamoto, Nobuhiro
    Chu, Po-Sung
    Shiba, Shunsuke
    Tahara, Toshiyuki
    Komatsu, Hirokazu
    Okamura, Yukishige
    Ojiro, Keisuke
    Kikuchi, Masahiro
    Aoki, Yu
    Yamaguchi, Akihiro
    Usui, Shingo
    Kanai, Takanori
    HEPATOLOGY, 2020, 72 : 689A - 689A
  • [39] The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Sakamoto, Azusa
    Marusawa, Hiroyuki
    Kojima, Yuji
    Hasebe, Chitomi
    Arai, Hirotaka
    Joko, Kouji
    Kondo, Masahiko
    Tsuji, Keiji
    Sohda, Tetsuro
    Kimura, Hiroyuki
    Ogawa, Chikara
    Uchida, Yasushi
    Wada, Shuichi
    Kobashi, Haruhiko
    Furuta, Koichiro
    Shigeno, Masaya
    Kusakabe, Atsunori
    Akahane, Takehiro
    Narita, Ryoichi
    Yoshida, Hideo
    Mitsuda, Akeri
    Ide, Yasushi
    Matsushita, Tomomichi
    Izumi, Namiki
    CANCERS, 2021, 13 (11)
  • [40] Real-world treatment patterns and survival in patients (pts) with hepatocellular carcinoma in the United States
    Morse, Michael
    Meyer, Anne-Marie
    Lawrance, Marcus
    Pereira, Marta
    Mhatre, Shivani K.
    Gaillard, Vincent
    Dayyani, Farshid
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345